Abstract:It is urgently required to develop the molecular agents with high therapeutic efficacy and low side effects for precise cancer therapy. Herein, an advanced multifunctional prodrug B-BDP-CL-CPT, consisting of a glutathione (GSH)-responsive boron dipyrromethene (BDP)-based photosensitizer, a chemo drug camptothecin (CPT), a reactive oxygen species (ROS)-sensitive chain linking BDP with CPT, and a biotin fragment with specific affinity to biotin-receptor, was designed and synthesized. Owing to the introduction of 2,4-dinitrobenzenesulfonate (DNBS) as the quencher into BDP core and chemical modification of CPT at the active site, B-BDP-CL-CPT is non-cytotoxic. Having biotin as the targeting ligand, the prodrug can be efficiently internalized by biotin-acceptor positive cancer cells, and then activated to generate substantial light-induced ROS through removal of the stopper DNBS by intracellular GSH which is abundant in cancer cells. The resulting ROS can not only serve for photodynamic therapy (PDT) but also further cleave thioketal linkage causing the release of CPT, to achieve dual PDT and chemotherapy. And the combination of preferential accumulation with specific activation in tumor tissues for this prodrug is conducive to improving the dual therapeutic outcome meanwhile greatly reducing the photo-damage and the release of CPT in adjacent healthy tissues. In addition, the activated B-BDP-CL-CPT can give bright fluorescence signals which are favor for imaging-guided PDT and real-time tracking the release of therapeutic agent. The in vitro and in vivo investigations have been performed to demonstrate the targeted and combined anticancer activities of this prodrug against HepG2 and HeLa cancer cells, and the mice with H22 tumors. This study proposes a new tactics for highly efficient and precise cancer treatment.

Cisplatin-appended BODIPY for near infrared II fluorescent and photoacoustic imaging-guided synergistic phototherapy and chemotherapy of cancer

Novel BODIPY-based Nano-Biomaterials with Enhanced D-A-D Structure for NIR-triggered Photodynamic and Photothermal Therapy

Near Infrared BODIPY-Platinum Conjugates for Imaging, Photodynamic Therapy and Chemotherapy

An aza-BODIPY photosensitizer for photoacoustic and photothermal imaging guided dual modal cancer phototherapy

Platinum-based Photosensitizer with Near-Infrared Aggregation-Induced Emission for Synergistic Photodynamic-Chemo Theranostics

D-A-D-structured Boron-Dipyrromethene with Aggregation-Induced Enhanced Phototherapeutic Efficiency for Near-Infrared Fluorescent and Photoacoustic Imaging-Guided Synergistic Photodynamic and Photothermal Cancer Therapy

Harnessing Dual Phototherapy and Immune Activation for Cancer Treatment: the Development and Application of BODIPY@F127 Nanoparticles.

NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy

Amphiphilic Redox-Sensitive NIR BODIPY Nanoparticles for Dual-Mode Imaging and Photothermal Therapy

The tumor phototherapeutic application of nanoparticles constructed by the relationship between PTT/PDT efficiency and 2,6-and 3,5-substituted BODIPY derivatives

Boron Dipyrromethene-Based Phototheranostics for Near Infrared Fluorescent and Photoacoustic Imaging-Guided Synchronous Photodynamic and Photothermal Therapy of Cancer

Fabrication of cisplatin-loaded polydopamine nanoparticles via supramolecular self-assembly for photoacoustic imaging guided chemo-photothermal cancer therapy

Synergistic photodynamic and photothermal therapy of BODIPY-conjugated hyaluronic acid nanoparticles

Single molecular-based nanoparticles with aggregation-induced emission characteristics for fluorescence imaging and efficient cancer phototherapy

PEGylated Dimeric BODIPY Photosensitizers As Nanocarriers for Combined Chemotherapy and Cathepsin B-Activated Photodynamic Therapy in 3D Tumor Spheroids.

An advanced multifunctional prodrug combining photodynamic therapy with chemotherapy for highly efficient and precise tumor ablation

Phototheranostic Agents Based on Nonionic Heptamethine Cyanine for Realizing Synergistic Cancer Phototherapy.

NIR and Reduction Dual-Sensitive Polymeric Prodrug Nanoparticles for Bioimaging and Combined Chemo-Phototherapy

Phototheranostic Agents Based on Non‐Ionic Heptamethine Cyanine for Realizing Synergistic Cancer Phototherapy

Amphiphilic porphyrin-based nanoparticles as a nuclei-approaching delivery platform for enhanced cancer photochemotherapy

Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles